Compare STTK & LOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STTK | LOCO |
|---|---|---|
| Founded | 2016 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 275.9M | 304.0M |
| IPO Year | 2020 | 2014 |
| Metric | STTK | LOCO |
|---|---|---|
| Price | $4.03 | $10.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | $6.20 | ★ $14.50 |
| AVG Volume (30 Days) | ★ 375.1K | 175.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 27.32 | 16.22 |
| EPS | N/A | ★ 0.68 |
| Revenue | $5,721,000.00 | ★ $401,701,000.00 |
| Revenue This Year | N/A | $5.42 |
| Revenue Next Year | N/A | $1.67 |
| P/E Ratio | ★ N/A | $16.00 |
| Revenue Growth | ★ 245.26 | 5.68 |
| 52 Week Low | $0.69 | $8.29 |
| 52 Week High | $4.89 | $11.74 |
| Indicator | STTK | LOCO |
|---|---|---|
| Relative Strength Index (RSI) | 51.33 | 54.19 |
| Support Level | $3.52 | $10.16 |
| Resistance Level | $4.23 | $10.90 |
| Average True Range (ATR) | 0.28 | 0.24 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 58.62 | 85.43 |
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. Restaurant locations are typically free-standing and include drive-thrus, and menus include many low-priced options. Poultry is the company's largest food cost, accounting for roughly 38% of total food and paper cost, and the company manages that commodity price risk by using multiple suppliers and entering supply contracts of varying lengths depending on market conditions.